| Literature DB >> 24900878 |
Stephen Hanessian1, Thomas Jennequin1, Nicolas Boyer1, Vincent Babonneau1, Udaykumar Soma1, Clotilde Mannoury la Cour2, Mark J Millan2, Guillaume De Nanteuil3.
Abstract
In connection with a program directed at potent and balanced dual NK1/NK3 receptor ligands, a focused exploration of an original class of peptidomimetic derivatives was performed. The rational design and molecular hybridization of a novel phenylalanine core series was achieved to maximize the in vitro affinity and antagonism at both human NK1 and NK3 receptors. This study led to the identification of a new potent dual NK1/NK3 antagonist with pK i values of 8.6 and 8.1, respectively.Entities:
Keywords: Schizophrenia; dual NK1/NK3 receptor antagonists; molecular hybridization; peptidomimetic
Year: 2014 PMID: 24900878 PMCID: PMC4027792 DOI: 10.1021/ml400528y
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345